News & Perspective

Mar 23, 2018

Mar 23, 2018

ASP Scan (Weekly) for Mar 23, 2018

Contact precautions and resistance
Antimicrobial use on farms
CARB-X funds antibiotic candidate
Resistance surveillance in poor nations
MDR-TB treatment outcomes
New stewardship e-book
Sepsis, diagnostics technology
Resistant TB in Europe
Appropriate C diff testing
Fast sepsis detection

Nov 09, 2012

Nov 09, 2012

BioCryst may drop quest for US approval of peramivir

(CIDRAP News) – BioCryst Pharmaceuticals Inc. signaled yesterday it will probably give up on seeking a US license for the influenza drug peramivir, a move that would reduce the already limited options for severely ill flu patients in need of an intravenous antiviral drug.

Sort Results By:

 Sort Results By:

Narrow results by:

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation 3MAccelerate DiagnosticsGilead 
Grant support for ASP provided by

  Become an underwriter»